CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Comaneci Embolization Assist Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04518670
NCT04518670N/ACompleted

Success in Comaneci-assist Coils Embolization Surveillance Study

Rapid Medical·observational·Posted Aug 19, 2020·Updated Jan 21, 2026

In Brief

An observational study evaluating Comaneci Embolization Assist Device for Intracranial Aneurysm. Completed, enrolled 90 participants across 8 sites.

Detailed Summary

The Comaneci Embolization Assist Device is indicated for use in the neurovasculature as a temporary endovascular device used to assist in the coil embolization of wide-necked intracranial aneurysms with a neck width ≤ 10 mm. A wide-necked intracranial aneurysm (IA) defines the neck width as ≥ 4 mm or a dome-to-neck ratio \< 2. The objective of the Postmarket Surveillance Plan is to assess safety and performance as used in postmarket clinical practice in the U.S.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedAug 19, 2020
Enrollment StartNov 24, 2020
Primary CompletionMay 1, 2024
Study CompletionJul 7, 2024
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 5.9 years ago

Interventions

Comaneci Embolization Assist Devicedevice

assist in the coil embolization of wide-necked intracranial aneurysms with a neck width ≤ 10 mm.